home / stock / lxxgf / lxxgf news

LXXGF News and Press, Lexagene Holdings From 09/12/19

Stock Information
Company Name: Lexagene Holdings
Stock Symbol: LXXGF
Market: OTC
Website: lexagene.com
Menu
LXXGF LXXGF Quote LXXGF Short LXXGF News LXXGF Articles LXXGF Message Board
Get LXXGF Alerts

News, Short Squeeze, Breakout and More Instantly...
LXXGF - LexaGene Announces its Second Hemp-Cannabis Reference Testing Laboratory as a Beta Test Site

BEVERLY, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene”) or the (“Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers,...
LXXGF - LexaGene Reports on Beta Results from Cannabis-Focused Testing Laboratory

BEVERLY, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today that in Augus...

LXXGF - LexaGene Holdings Inc. Joins The Stock Day Podcast to Announce Successful Beta Testing

Phoenix, Arizona--(Newsfile Corp. - August 20, 2019) - The Stock Day Podcast welcomed LexaGene Holdings, Inc. (OTCQB: LXXGF) ("the Company") , a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary dia...

LXXGF - LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory

BEVERLY, Mass., Aug. 08, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today it has an agre...
LXXGF - LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples to Test for Superbugs

BEVERLY, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced today that it has been rec...

LXXGF - LexaGene Files Three Additional US Patents Covering Technology

BEVERLY, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced today that it has filed additional pat...

LXXGF - LexaGene's Beta Prototype Exceeds Expectations During Testing at Massachusetts Veterinary Referral Hospital

BEVERLY, Mass., July 10, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today the test resul...
LXXGF - LexaGene Will Host a Free Webinar Providing an Overview of the Company

BEVERLY, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announce that LexaGene will ho...

LXXGF - LexaGene Places its First Beta Prototype into Massachusetts Veterinary Referral Hospital

BEVERLY, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today that it has pl...

LXXGF - LexaGene Completes Development of Antibiotic Resistance Panel

BEVERLY, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today that it has completed t...
Previous 10 Next 10